News
What’s in it for us? Benefits of European HTA Non-Duplication
“HTA cooperation produces and will produce very tangible benefits not only for patients, but also improve the quality and sustainability of health systems when Europe
EUnetHTA Magazine – Summer 2018
EUnetHTA Magazine – Summer 2018 HERE HTA Proposal: Is It Lights Out?; HTA reports; Impact: Lithuania; Interview: EURORDIS; Partner Profile: Poland; Non-Duplication: What’s in it
OTCA16 Bioresorbable Stents in cardiovascular indications (coronary artery disease) Project Plan Now Available
The final project plan of the assessment on “Bioresorbable Stents in cardiovascular indications (coronary artery disease)” and the comments provided by the external experts and
The Joint Assessment, OTJA08, on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin” is now available.
We are pleased to announce that the joint rapid assessment on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems
OTJA10 “Stool DNA testing for early detection of colorectal cancer” Final Project Plan Now Available
[vc_row][vc_column][vc_column_text]This is the final project plan of the assessment on Stool DNA testing for early detection of colorectal cancer. Download Final Project Plan HERE Download
OTCA14 “Robotic surgery in thoracic and visceral indications” Final Project Plan and Combined Comments Now Available
This is the final project plan of the assessment on robotic surgery in thoracic and visceral indications. The combined comments from external experts and the
A Visual Summary of the May 2018 EUnetHTA Forum from Cologne, Germany
[vc_row][vc_column][vc_video link=”https://www.youtube.com/watch?v=zrOcLSvYmQU&feature=youtu.be” title=”2018 EUnetHTA Forum”][/vc_column][/vc_row]
Patient group input requested for a new Joint Assessment on a medicinal product for Diabetes Type 1 – Closing August 3
EUnetHTA Joint Production is pleased to announce the launch of the REA for Sotagliflozin for Type 1 diabetes mellitus (PTJA04) For this specific assessment on
Materials now available from 1st EUnetHTA Workshop on HTA and MDR/IVDR (from 29th May 2018, Vienna) and 2nd Workshop Announced (28 May, 2019, Vienna)
We are happy to announce that the documentation of the 1st EUnetHTA Workshop on HTA and MDR/IVDR (from 29th May 2018, Vienna) is now available.
September 3, 2018 – Real-World Evidence in Medicine Development – An online introductory course – call for registration
Real-World Evidence in Medicine Development An online introductory course Under the supervision of leading academics involved in the IMI GetReal project, this interactive online course
